Biotech
TORONTO, ONTARIO: - Advancing the two ongoing clinical trials with TTI-621, an IgG1 SIRPaFc fusion protein targeting CD47; updated data anticipated in 2H/2017 - Expanding the CD47 franchise with TTI-622, an IgG4 SIRPaF ...
MIAMI, FL: $1.8M Gross Income and $1.0M Net Profit Year to Date. ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 01/31/17 -- Invivoscribe® Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the fields ...
PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 01/31/17 -- (NASDAQ: GNMX) (the Company) announced today that the first patient has been dosed in a Phase 1/2 clinical trial to assess the efficacy of its lead i ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/31/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TR), a clinical-stage immuno-oncology company developing innovative therapies for the treatment of canc ...
SCOTTSDALE, ARIZONA: New core product sales increase 147% fourth quarter over fourth quarter ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 01/30/17 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, dev ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/17 -- This document corrects and replaces the press release that was sent today at 8:00 am ET. The embedded URL was changed.Calyx Bio-Ventures In ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/17 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") is pleased to provide an update on its ongoing b ...
NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 01/27/17 -- iBio, Inc. (NYSE MKT: IBIO) On January 20, 2017, the Supreme Court for the State of New York, County of New York, scheduled a hearing to consider approval ...
BASEL, SWITZERLAND: BASEL, SWITZERLAND -- (Marketwired) -- 01/26/17 -- Cellestia Biotech AG -Basel, Switzerland - January 26, 2017 - Cellestia Biotech AG, a private biopharmaceutical company with strategic focus on anti ...
GUILDFORD, UNITED KINGDOM: GUILDFORD, UNITED KINGDOM -- (Marketwired) -- 01/26/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)AIM:AGL OTCQX:ANPCYPatient enrolment European study now over 90% complete and US study 70% complete; Headl ...
CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwired) -- 01/25/17 -- Wood Capital Ltd. ("Wood Capital") an entity controlled by Blake Wood, acquired a CDN$1,000,000 convertible debenture (the "Debenture& ...
CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwired) -- 01/25/17 -- Drive Capital Corp. ("Drive Capital") an entity controlled by Jed M. Wood, acquired a CDN$1,000,000 convertible debenture (the "Debent ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 01/25/17 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX)Noninfectious Anterior Uveitis: Enrollment of first-ever vehicle-controlled Phase 3 clinical trial is expected t ...
WALTHAM, MA: Life Sciences Software Executive to Lead Commercial Team ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 01/22/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company") announces that the submission titled "TACTI-mel, Two A ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 01/19/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company") today announced the first patient has been dosed as part of ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 01/18/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) the "Company" has received notification from the Listing Qualifications Department of the NASDAQ ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 01/17/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) announces that the abstract submitted by its partner, TaiMed Biologics, Inc., for the 24-week st ...
